Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A dietary supplement combination containing **mulberry leaf extract**, **white kidney bean extract**, and **cinnamon**. This blend is marketed to support healthy blood sugar metabolism and insulin balance. Mulberry leaf extract, standardized for 1-deoxynojirimycin, is believed to reduce dietary sugar and carbohydrate absorption by inhibiting carbohydrate-digesting enzymes in the gut. White kidney bean extract acts as an alpha-amylase inhibitor, also contributing to reduced breakdown and absorption of carbohydrates, thus potentially lowering post-meal glycemic spikes. Cinnamon (typically Cinnamomum cassia bark extract) may enhance the body's insulin sensitivity and glucose metabolism, with effects attributed to its polyphenol content. The combination, often formulated in capsule form, is consumed orally, typically prior to carbohydrate-containing meals, to assist in maintaining stable blood glucose levels. These supplements are widely available, produced by multiple manufacturers, but are not recognized as pharmaceutical drugs or approved to treat, cure, or prevent any disease by major regulatory bodies[1][2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mulberry leaf extract + white kidney bean extract + cinnamon.